BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Dec. 7, 2022

Dec. 7, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Quanterix, Reveal Genomics.
Read More

In the clinic for Dec. 7, 2022

Dec. 7, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzheon, Biovie, Cassava, Celldex, Dragonfly, Editas, Gossamer, Imaginab, Kinarus, Leo, Medicinova, Mirati.
Read More

In the clinic for Dec. 6, 2022

Dec. 6, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Altpep, Emulate.
Read More

In the clinic for Dec. 6, 2022

Dec. 6, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agendia, Altpep, Emulate.
Read More

In the clinic for Nov. 29-Dec. 5, 2022

Dec. 6, 2022
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Atea, Biogen, Clover, Eisai, H. Lundbeck, Henlius, Intravacc, Kintor, Kira, Otsuka, Providence, Qilu, Qurient, Sorrento, Vaxxinity.
Read More

In the clinic for Dec. 6, 2022

Dec. 6, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcutis, Bioage, Denali, Ellipses, First Wave, Hepion, Hillevax, Innovent, Longboard, Lynk, Neurona, Nkarta, Novartis, Qilu, Stoke, Syndax, Urogen, Valneva, Zynerba.
Read More

In the clinic for Dec. 5, 2022

Dec. 5, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Delcath Systems, Sema4.
Read More

In the clinic for Dec. 5, 2022

Dec. 5, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Altamira, Anavex, EIP, H. Lundbeck, Mirati, Ondine, Otsuka, Qilu, SK, Theratechnologies, Urogen, Vanda, Vaxxinity, Ventyx.
Read More

In the clinic for Dec. 2, 2022

Dec. 2, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lucid Diagnostics.
Read More

In the clinic for Dec. 2, 2022

Dec. 2, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: .
Read More
Previous 1 2 … 158 159 160 161 162 163 164 165 166 … 322 323 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 30, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing